BioCentury
ARTICLE | Company News

SynGenix, Glaxo Wellcome deal

November 6, 2000 8:00 AM UTC

GLXO will use Syngenix’s ProVector neuronal drug delivery technology with a GLXO compound to treat neuropathic pain. SynGenix said the technology, which uses axonal transport to deliver compounds to n...